HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Fangxiang Xiao Selected Research

Fangxiang Xiao Research Topics

Disease

3Neoplasms (Cancer)
01/2023 - 11/2016
2Breast Neoplasms (Breast Cancer)
01/2023 - 11/2016
1Renal Cell Carcinoma (Grawitz Tumor)
01/2023
1Uveal melanoma
01/2023
1Nasopharyngeal Carcinoma
01/2023
1Esophageal Squamous Cell Carcinoma
01/2023
1Hepatocellular Carcinoma (Hepatoma)
01/2023
1Ovarian Neoplasms (Ovarian Cancer)
01/2023
1Prostatic Neoplasms (Prostate Cancer)
01/2023
1Stomach Neoplasms (Stomach Cancer)
01/2023
1Colorectal Neoplasms (Colorectal Cancer)
01/2023
1Chromosome Aberrations (Chromosome Abnormalities)
12/2016
1Body Weight (Weight, Body)
12/2016
1Triple Negative Breast Neoplasms
11/2016
1Necrosis
12/2015
1Inflammation (Inflammations)
01/2015

Drug/Important Bio-Agent (IBA)

2Proteins (Proteins, Gene)FDA Link
01/2023 - 11/2016
1Environmental BiomarkersIBA
01/2023
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
01/2023
1Biomarkers (Surrogate Marker)IBA
01/2023
1Oncogene Proteins (Oncogene Protein)IBA
01/2023
1Eph Family Receptors (Eph Receptors)IBA
01/2023
1EphA1 Receptor (Eph Receptor)IBA
01/2023
1Ephrin-A1 (Ephrin A1)IBA
01/2023
1Mitomycin (Mitomycin-C)FDA LinkGeneric
12/2016
1Antimutagenic Agents (Antimutagens)IBA
12/2016
1Cytochromes c (Cytochrome c)IBA
11/2016
1Polysaccharides (Glycans)IBA
11/2016
1CaspasesIBA
11/2016
1Guanosine Triphosphate (GTP)IBA
12/2015
1Interleukin-6 (Interleukin 6)IBA
12/2015
1AntioxidantsIBA
01/2015

Therapy/Procedure

3Therapeutics
01/2023 - 11/2016